Invited international speakers
Birmingham, UK View bio
Wiebke Arlt Birmingham, UK
Professor Wiebke Arlt is the William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham.
She leads a large inter-disciplinary research group investigating androgen synthesis and metabolism, both in the context of rare adrenal and gonadal disorders and common disease with increased metabolic risk such as adrenal tumours and polycystic ovary syndrome.
Cambridge, UK View bio
Jason Carroll Cambridge, UK
Jason is an Australian who completed a PhD in 2002 at the University of New South Wales and the Garvan Institute, Sydney, with Prof Robert Sutherland. He conducted postdoctoral work with Prof. Myles Brown at Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA from 2002-2006. He has been running his own group at Cancer Research UK, Cambridge Institute and University of Cambridge since 2006. He is currently a senior group leader at Cancer Research UK, a Director of Research at University of Cambridge, a Fellow at Clare College and was elected an EMBO member in 2016 and a Fellow of the Academy of Medical Sciences in 2017. His lab is interested in understanding mechanisms of hormone-dependent cancer.
Bern, Switzerland View bio
Christa Flück Bern, Switzerland
Christa E. Flück is Professor for Pediatric Endocrinology and Diabetology at the Bern University Children’s Hospital in Bern, Switzerland.
She was trained in Pediatrics and Pediatric Endocrinology and Diabetology in Lucerne and Bern, Switzerland, and did a postdoctoral research fellowship at the University of California in San Francisco, USA, where she started her research career in the field of molecular endocrinology of steroid hormone biosynthesis with Prof. Walter L. Miller.
Her own research group of 13 years at the University of Bern studies patients with rare disorders of steroidogenesis and disorders of sex development. Her group also investigates regulatory mechanisms controlling human androgen production and novel androgen producing pathways (e.g. the backdoor pathway) using omics approaches. She is Swiss representative of the COST action DSDnet and the present coordinator of the DSD working group of ESPE.
Berlin, Germany View bio
Sebastiaan Meijsing Berlin, Germany
Dr. Sebastiaan Meijsing is group leader at the Max Planck Institute for molecular genetics and guest lecturer at the Freie Universität Berlin, Germany.
He studied in Leiden and obtained his PhD from the Humboldt University Berlin for work on transcriptional silencing. Subsequently, he joined the lab of Keith Yamamoto where he investigated mechanisms that regulate the dynamic association of the glucocorticoid receptor with DNA and the role of DNA as an allosteric ligand, which modulates the structure and activity of associated proteins.
His current work is aimed at understanding how the integration of signals fine-tunes the activity of the glucocorticoid receptor towards individual genes. Another goal is to unravel how genomic binding of transcription factors is linked to the transcriptional regulation of endogenous target genes using a combination of genomics and genome engineering approaches.
Ann Arbor, USA View bio
William (Bill) Rainey, Ph.DAnn Arbor, USA
Bill Rainey received his Ph.D. from the University of Texas, Southwestern Medical Center in Dallas, Texas.
He completed his post-doctoral training in INSERM research units in Grenoble and Lyon, France. Dr. Rainey is a research endocrinologist specializing in adrenal tumor development, adrenal cortex zonation, and adrenal steroid hormone production. His research group has authored over 200 peer-reviewed publications and been continuously funded by the National Institutes of Health and American Heart Association for 30 years.
Dr. Rainey served as the American Editor for Molecular and Cellular Endocrinology and is on the editorial boards of several other endocrine journals. He is currently the Jerome Conn Professor in the Departments of Molecular and Integrative Physiology and Internal Medicine at the University of Michigan.
Dr. Rainey’s group now focuses on the mechanisms causing dysregulation of steroid hormone biosynthesis in adrenal disease.
Cleveland, USA View bio
Nima Sharifi Cleveland, USA
Nima Sharifi, M.D., is the Kendrick Family Endowed Chair for Prostate Cancer Research and Co-Director of the Prostate Cancer Research Center of Excellence at Cleveland Clinic, Co-Leader of the GU Malignancies Program of the Case Comprehensive Cancer Center and Associate Professor in the Department of Molecular Medicine at Cleveland Clinic Lerner College of Medicine and the Department of Pharmacology at Case Western Reserve University.
His medical oncology clinic is focused on prostate cancer and his laboratory is focused on the discovery and clinical implications of new mechanisms of hormone therapy resistance. Sharifi’s laboratory discovered a gain-of-function in a germline variant of a steroidogenic enzyme that increases synthesis of dihydrotestosterone from extragonadal precursor steroids and hastens the clinical development of castration-resistant prostate cancer.
He is the recipient of the AACR Award for Outstanding Achievement in Cancer Research, the Howard Hughes Medical Institute Physician-Scientist Early Career Award, the Richard E. Weitzman Award of the Endocrine Society and is an elected member of the American Society for Clinical Investigation.
Cleveland, USA View bio
Wulf Utian Cleveland, USA
Wulf H. Utian MB.BCh, PhD, DSc, FRCOG, FACOG, FICS, is a physician reproductive endocrinologist, and world-renowned researcher, author, and lecturer on menopause & infertility. He was an early pioneer in the development of in vitro fertilization, and started the world’s first research center on menopause in 1967 at the University of Cape Town in South Africa. Among numerous awards, he was honored by Good Housekeeping as “one of America’s best physicians in women’s health,” by Ladies Home Journal as one of the “top ten researchers in women’s health” and by the FDA with an FDA Citation “for the collective outstanding performance of the ‘Menopause and Hormones Information Campaign’.”
He is an independent consultant in women’s health issues, especially regarding new drug development. Considered to be one of the world’s most significant authorities on menopause and women’s health, Dr. Utian is Professor Emeritus of Reproductive Biology, Case Western Reserve University School of Medicine; Consultant to the Cleveland Clinic; Chairman of the Scientific Advisory Board of Rapid Medical Research; and Executive Director Emeritus of the North American Menopause Society (NAMS). Previously, he was Director of Obstetrics and Gynecology at University Hospitals of Cleveland and Chairman of Reproductive Biology at Case Western Reserve University.
He received his medical degree from the University of the Witwatersrand, Johannesburg, South Africa, and his PhD from the University of Cape Town, South Africa. In 2007 he earned the DSc (Med) degree from the University of Cape Town, it’s highest degree and awarded only 11 times in almost 100 years. He is Board Certified in Obstetrics and Gynecology and Reproductive Endocrinology.
He is one of the three original Founders in 1976 of the International Menopause Society, of which he is Honorary Past President, and founder of both the Council of Affiliated Menopause Societies (CAMS), and the North American Menopause Society (NAMS). He is the recipient of multiple research grants and awards and has studied the metabolic and psychosocial aspects of hormones and menopause for many years. He was Medical Editor of Maturitas from 1983-1993, is Honorary Founding Editor of Menopause (1994-2017), and was Editor of Menopause Management from its inception in 1987 until December 2009.
During his career, Dr. Utian has written over 200 scientific papers related to women’s health, multiple editorials, and has authored several books, including eight on menopause, the latest consumer-oriented book titled “CHANGE YOUR MENOPAUSE – Why one size does not fit all”, and his successful self-help book, “THE UTIAN STRATEGY – Is this your problem or is this my problem?”